Havens Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Havens Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-75,000	Closed	-$3.88M	–	45
2022 Q3	$3.88M	Buy	+75,000	New	+$3.1M	5.8%	2

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Havens Advisors's CCXI Position: Q4 2022 in Review

Havens Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 75,000 shares — an estimated $3.88M sold.

Havens Advisors first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $3.88M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Havens Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Havens Advisors sold 75,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $3.88M.
Havens Advisors first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
Havens Advisors's ChemoCentryx, Inc. position peaked at $3.88M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Havens Advisors's 13F filing for Q4 2022, filed 25 Jan 2023.